CasInvent Pharma’s approach is aimed at three forms of cancer rather than just one, with leukaemia, lymphoma and solid tumours all in its sights.

Non-recyclable plastics making asphalt more sustainable and a vaccine to save the honeybee are just two of 10 inventions that caught our eye.

Phil Clare has joined Queen Mary Innovation as chief executive, having previously worked for University of Oxford since 2006.

Could we save the environment one parcel at a time? Politecnico di Milano’s packaging technology spinout Voidless hopes so.

About half of all vaccines are wasted due to challenges surrounding cold chain logistics, so EnsiliTech aims to remove the need for cold storage.

Sean Fielding has worked for University of Exeter for nearly three decades, during which time his board memberships included ATTP, SETsquared and PraxisAuril.

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

Maxine Ficarra has been with the organisation since its original incarnation of Praxis Courses and CEO since it became PraxisAuril in 2017.

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.

Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.